Pure Global

Endovascular Intervention Using Fluorescence Guidance - Vietnam Registration 2403314ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Endovascular Intervention Using Fluorescence Guidance in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2403314ĐKLH/BYT-HTTB and manufactured by Rontis Corporation SA. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN CÔNG NGHỆ SINH HỌC KIM HÒA PHÁT.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2403314ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403314ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Endovascular Intervention Using Fluorescence Guidance
VN: Bóng nong dùng trong can thiệp ngoại vi
Risk Class TTBYT Loại D

Registration Details

2403314ĐKLH/BYT-HTTB

19008638/ĐKLH-BYT-TB-CT

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Rontis Corporation SA

Technical Details

The product is designed for use in the treatment of peripheral arterial occlusive disease (PAOD) at the peripheral vascular system: Femoral artery and popliteal artery, Femoral artery, Renal artery, Sub-renal aorta, Mesenteric artery, Arteriovenous fistulae of the kidneys

Dates and Status

Nov 06, 2024